Status:
UNKNOWN
The Effect of Lifestyle Intervention for Hypertriglyceridemia on the Pathogenesis of Adverse Pregnancy Outcome
Lead Sponsor:
National Taiwan University Hospital
Conditions:
Hypertriglyceridemia During Pregnancy
Eligibility:
FEMALE
20+ years
Phase:
NA
Brief Summary
During pregnancy, hypertriglyceridemia is associated with adverse pregnancy outcomes, including gestational hypertension, preeclampsia, gestational diabetes mellitus, large for gestational age (LGA), ...
Eligibility Criteria
Inclusion
- Pregnant women older than 20-year-old
- During GA 24-28+6 weeks
- Carrying a singleton
- Having hypertriglyceridemia (plasma triglyceride at GA 24-28+6 excess 246 mg/dL but not higher than 1000 mg/dL).
Exclusion
- Using steroid
- Using anti-platelet or anti-coagulant
- Using lipid-lowering agents
- Hypertriglyceridemia is caused by secondary cause, such as hypothyroidism, cushing syndrome, nephrotic syndrome, alcohol use or medication use.
- Have been diagnosed with chronic hypertension, overt diabetes mellitus, gestational diabetes mellitus, secondary hypertriglyceridemia, autoimmune disease, or malignancy.
- Have received the artificial fertilization.
- Not having fetus echography examination at GA 22-23+6
- Not going to deliver the baby at National Taiwan University Hospital
- Have underwent other clinical trials
Key Trial Info
Start Date :
March 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 31 2022
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT04275622
Start Date
March 1 2020
End Date
March 31 2022
Last Update
February 19 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Taiwan University Hospital
Taipei, Taiwan